Support 100 years of independent journalism.

  1. Science & Tech
  2. Coronavirus
28 April 2020updated 06 Oct 2020 9:45am

Oxford vaccine team hopeful of millions of doses by September after promising tests in monkeys

By Samuel Horti

The team of government-backed Oxford scientists racing to produce a vaccine have said they are hopeful of having millions of doses ready by September, following promising tests in rhesus macaque monkeys.

Scientists at the National Institutes of Health’s Rocky Mountain Laboratory in Montana inoculated six monkeys with a single dose of the vaccine last month, and then exposed the animals to heavy quantities of coronavirus. The exposure had consistently sickened other monkeys in the lab, researchers told the New York Times, but a month later all six inoculated monkeys were healthy. “The rhesus macaque is pretty much the closest thing we have to humans,” one researcher said.

Researchers at the Oxford Vaccine Group and Oxford’s Jenner Institute, who are already testing the vaccine in humans, told the paper that they hoped to have tested 6,000 people by the end of next month, and to have millions of doses available by September.

Sign up for The New Statesman’s newsletters Tick the boxes of the newsletters you would like to receive. Quick and essential guide to domestic and global politics from the New Statesman's politics team. The New Statesman’s global affairs newsletter, every Monday and Friday. The best of the New Statesman, delivered to your inbox every weekday morning. A handy, three-minute glance at the week ahead in companies, markets, regulation and investment, landing in your inbox every Monday morning. Our weekly culture newsletter – from books and art to pop culture and memes – sent every Friday. A weekly round-up of some of the best articles featured in the most recent issue of the New Statesman, sent each Saturday. A weekly dig into the New Statesman’s archive of over 100 years of stellar and influential journalism, sent each Wednesday. Sign up to receive information regarding NS events, subscription offers & product updates.
I consent to New Statesman Media Group collecting my details provided via this form in accordance with the Privacy Policy